D.A. Davidson analyst Gary Tenner maintained a Buy rating on United Community Banks (UCB – Research Report) today and set a price target ...

Truist lowered the firm’s price target on United Community Banks (UCB) to $30 from $32 and keeps a Hold rating on the shares as part of ...

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...

UCB recently hosted the orientation programme for this year’s third intake of the Monash College Diploma programme.

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...

United Community Banks Inc (NYSE:UCB) is set to release its Q3 2024 earnings on Oct 23, 2024. The consensus estimate for Q3 ...

For the quarter ended September 2024, United Community Banks (UCB) reported revenue of $244.49 million, up 4.3% over the same ...

United Community Banks, Inc. (NYSE:UCB) Q3 2024 Earnings Call Transcript October 23, 2024 Operator: Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the ...

Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the call today are Chairman and Chief Executive Officer Lynn Harton, Chief Financial Officer Jefferson ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...